CAAW26 Evidence into Practice award winners announced

This project aimed to strengthen secondary fracture prevention by improving fragility fracture identification and management, using audit. The team designed and implemented a digitally-enabled model that replaced multi-step referrals with a streamlined, system-wide automated identification process. With poor case ascertainment at the outset (22.7% in 2021), identification rose to 80% (3,015 cases) in 2025, double the national benchmark of 40% (and achieved five years earlier than planned).

This project (Service Redesign and Capacity Improvement Through Nurse Practitioner Role Expansion in the Prostate Biopsy Pathway) uses audit to address critical delays between clinic review and LATP biopsy, and improve outcomes for prostate cancer patients. The result was an increase in clinic capacity by 33.3% and biopsy capacity by 37.5%, without requiring additional consultant sessions or theatre lists; maximising the use of limited resources and demonstrating evidence into practice. 

This project was designed as a structured, multi-cycle clinical audit to evaluate compliance with policy and guidelines of Clozapine, an antipsychotic medication with risk of fatal side effects. It combined robust quantitative monitoring with multidisciplinary qualitative analysis, enabling clear identification of issues, to deliver a strong foundation for evidence-informed change. Across the three cycles, the audit demonstrated transformational improvements and sustained adoption.